Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERα.

Author information

Affiliations

  • 1. Cancer Institute, The Second Hospital of Dalian Medical University, Dalian Key Laboratory of Molecular Targeted Cancer Therapy, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
      Authors
    • Ding J 1
    • Wang X 1
    • Zhang Y 1
    • Sang X 1
    • Yi J 1
    • Liu C 1
    • Liu Z 1
    • Wang M 1
    • Zhang N 1
    • Xue Y 1
    • Shen L 1
    • Cheng H 1
    (12 authors)
  • 2. Department of Orthopedics, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
      Authors
    • Zhao W 2
    (1 author)
  • 3. Department of Acute Abdomen Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
      Authors
    • Luo F 3
    (1 author)
  • 4. Cancer Institute, The Second Hospital of Dalian Medical University, Dalian Key Laboratory of Molecular Targeted Cancer Therapy, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China; College of Pharmacy, Dalian Medical University, Dalian, Liaoning, China.
      Authors
    • Liu P 4
    (1 author)

ORCIDs linked to this article

Cancer Letters, 10 Oct 2018, 440-441:54-63
https://doi.org/10.1016/j.canlet.2018.09.030 PMID: 30315845 

Abstract 

Selective phosphatidylinositol 3 kinase (PI3K) inhibitors are being actively tested in clinical trials for ERα-positive (ER+) breast cancer due to the presence of activating PIK3CA mutations. However, recent studies have revealed that increased ERα transcriptional activity limits the efficacy of PI3K inhibitor monotherapy for ER + breast cancers. Herein, we report the identification of BTF3 as an oncogenic transcription factor that regulates ERα expression in luminal breast cancers. Our TCGA analysis reveals high expression levels of BTF3 in luminal/ER + breast cancer and cell line models harboring ERα overexpression. Concordantly, BTF3 expression is highly and strongly associated with ESR1 expression in multiple breast cancer cohorts. We further show that BTF3 promotes the proliferation, survival and migration of ER + breast cancer cells by modulating ESR1 expression and ERα-dependent transcription. Moreover, BTF3 knockdown sensitizes ER + breast cancer cells to the PI3Kα inhibitor BYL-719 in both in vitro and in vivo models. Together, our findings highlight a novel role of BTF3 in modulation of ERα-dependent transcriptional activity and its potential as a predictive marker for the response to PI3K-targeted therapy in ER + breast cancer.

Full text links 

Read article at publisher's site: https://doi.org/10.1016/j.canlet.2018.09.030

Citations & impact 

Impact metrics

15
Citations
Jump to Citations
10
Data citations
Jump to Data

Citations of article over time

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1016/j.canlet.2018.09.030

Supporting
Mentioning
Contrasting
0
20
0

Article citations

Go to all (15) article citations

Data 

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Funding 

Funders who supported this work.

Liaoning Provincial Climbing Scholars

    Liaoning Provincial Key Basic Research Program for Colleges and Universities (1)

    Liaoning Provincial Science and Technology Program for Oversea Talents

      National Natural Science Foundation of China (4)

      Provincial Natural Science Foundation of Liaoning (2)